Adial Pharmaceuticals Inc...

0.66
-0.01 (-2.19%)
At close: Apr 04, 2025, 10:16 AM

Adial Pharmaceuticals Statistics

Share Statistics

Adial Pharmaceuticals has 6.57M shares outstanding. The number of shares has increased by 55.31% in one year.

Shares Outstanding 6.57M
Shares Change (YoY) 55.31%
Shares Change (QoQ) 1.54%
Owned by Institutions (%) 0.06%
Shares Floating 6.46M
Failed to Deliver (FTD) Shares 6.69K
FTD / Avg. Volume 0.81%

Short Selling Information

The latest short interest is 78.88K, so 1.22% of the outstanding shares have been sold short.

Short Interest 78.88K
Short % of Shares Out 1.22%
Short % of Float 1.24%
Short Ratio (days to cover) 0.65

Valuation Ratios

The PE ratio is -1.42 and the forward PE ratio is -0.59. Adial Pharmaceuticals's PEG ratio is 0.02.

PE Ratio -1.42
Forward PE -0.59
PS Ratio 0
Forward PS 0.1
PB Ratio 4.62
P/FCF Ratio -2.71
PEG Ratio 0.02
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Adial Pharmaceuticals.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.16, with a Debt / Equity ratio of 0.

Current Ratio 4.16
Quick Ratio 4.16
Debt / Equity 0
Debt / EBITDA 0
Debt / FCF 0
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-2.64M
Employee Count 5
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -42.62% in the last 52 weeks. The beta is 1.26, so Adial Pharmaceuticals's price volatility has been higher than the market average.

Beta 1.26
52-Week Price Change -42.62%
50-Day Moving Average 0.76
200-Day Moving Average 0.98
Relative Strength Index (RSI) 43.8
Average Volume (20 Days) 830.41K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -8.28M
Net Income -13.2M
EBITDA -8.28M
EBIT n/a
Earnings Per Share (EPS) -0.71
Full Income Statement

Balance Sheet

The company has 3.75M in cash and 0 in debt, giving a net cash position of 3.75M.

Cash & Cash Equivalents 3.75M
Total Debt 0
Net Cash 3.75M
Retained Earnings -82M
Total Assets 5.04M
Working Capital 3.08M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.92M and capital expenditures 0, giving a free cash flow of -6.92M.

Operating Cash Flow -6.92M
Capital Expenditures 0
Free Cash Flow -6.92M
FCF Per Share -0.37
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ADIL does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for ADIL is $8, which is 1042.9% higher than the current price. The consensus rating is "Buy".

Price Target $8
Price Target Difference 1042.9%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Stock Splits

The last stock split was on Aug 7, 2023. It was a backward split with a ratio of 1:25.

Last Split Date Aug 7, 2023
Split Type backward
Split Ratio 1:25

Scores

Altman Z-Score -24.87
Piotroski F-Score 1